Latest Headlines

  1. IDBS Launches The E-WorkBook Cloud: Combining The Most Powerful R&D Software Platform With The Benefits And Flexibility Of The Cloud

    IDBS has today launched The E-WorkBook Cloud, an enterprise, Cloud-based platform designed specifically to meet the future challenges of scientific and R&D data management.

  2. Peli BioThermal Launches New CoolPall Vertos Advance

    Peli BioThermal, who specialise in the design and manufacturing of temperature-controlled packaging serving the life sciences and pharmaceuticals industry, has launched its new CoolPall Vertos Advance.

  3. CPhI Worldwide Experts Make Pharma Predictions For 2017: The Good, The Bad, And The Donald

    The CPhI Worldwide expert panel predicts pharma’s biggest opportunities and threats in 2017 – the wider industry, attendees and exhibitors increasingly look to the CPhI global events as a key indicator of future trends and partnerships.

  4. Leak Detection Equipment Highlights Pharmapack Paris 2017 Conference

    CCIT, a PTI affiliate, provides world class leak detection equipment, testing services and consulting for package quality testing throughout Europe.

  5. SP Scientific Announces A New Dedicated Website For Advanced Aseptic Processing Equipment

    SP Scientific announces the launch of a new dedicated website** for its PennTech® brand of advanced aseptic processing equipment for the pharmaceutical and biotech industries.

  6. Clovis Oncology Announces Proposed Offering Of Common Stock

    Clovis Oncology, Inc. announced recently that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $175M.

  7. Lonza Purchases Custom Built Cleanroom / POD To Manufacture Cell Therapy Products

    G-CON today announced the completion and delivery of a custom built cleanroom POD® system to Lonza for the manufacture of virally-modified cell therapy products in Houston, TX.

  8. Adding Multimedia And Conference Call Details Clovis Oncology Announces FDA Accelerated Approval Of Rubraca (Rucaparib) For The Monotherapy Treatment Of Advanced Ovarian Cancer In Women With Deleterious Germline Or Somatic BRCA Mutations

    Clovis Oncology, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved Rubraca (rucaparib) tablets as monotherapy for the treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer, who have been treated with two or more chemotherapies, and selected for therapy based on an FDA-approved companion diagnostic for Rubraca.

  9. Life Science Connect Appoints Chief Editor And Business Development Positions

    Life Science Connect, a business unit within the pioneering B2B media services company VertMarkets, announced two new appointments to the company’s Life Sciences team. Bob Marshall joins the Life Science Connect team as the Editor In Chief of Med Device Online.

  10. Sartorius Stedim Announces Expansion Of Sartorius Stedim Cellca

    Sartorius Stedim Cellca based near Ulm in southern Germany, continues on the growth track.